Pacific Edge shares up 3.8% on US insurance provider deal

Pacific Edge shares up 3.8% on US insurance provider deal
Sophie Boot
By Sophie Boot Feb. 7 (BusinessDesk) - Pacific Edge's shares jumped despite broad-based selling on the local index today, after the cancer diagnostics company announced a deal with a US insurance provider network.  In a statement to the NZX, Pacific Edge said its agreement with MediNcrease Health Plans will make its Cxbladder tests available to 5.5 million covered lives through its clients and payers. Cxbladder is a suite of non-invasive laboratory tests for the detection and management of bladder cancer.  The shares rose 3.8 percent t...